Trial intelligence / Profile preview

Non-inferiority of Kollagenase vs Iruxol for Cutaneous Ulcers

NCT00701974Phase 3Suspended

Sponsor
Azidus Laboratories Limited
Start
Feb 2008
Primary completion
Feb 2008
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 3 trial of collagenase clostridium histolyticum in Cutaneous ulcer, sponsored by Azidus Laboratories Limited. Started Feb 2008; status: suspended.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

Cutaneous ulcer

Beyond the preview

Go deeper on NCT00701974.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00701974.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call